Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction

Completed

Conditions studied: Meibomian Glands

In brief

This is an exploratory study to evaluate endpoints used to characterize participants with and without meibomian gland dysfunction (MGD) and will evaluate the correlation between signs and symptoms of MGD. No investigational drug will be administered in this study.

Key facts

Study ID

NCT01979887

Run by

Allergan

People needed

75

Starts

2013-11-01

Expected to finish

2014-07-01

Last updated by the study team

2014-08-15

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants characterized as with or without Meibomian Gland Dysfunction.

You may not qualify if…

• Lid heating therapy, therapeutic gland expression, or meibomian gland probing within 12 months of enrollment
• Contact lens use in the 30 days prior to enrollment
• Lid hygiene within 48 hours prior to enrollment
• Use of eye makeup within 8 hours of enrollment
• Eyelash growth-stimulating products within 30 days prior to enrollment
• Use of systemic vitamins and/or systemic supplements containing omega 3 fatty acids within 60 days of enrollment
• Use of systemic anti-histamines within 30 days prior to enrollment.

Where it is running

• Study site — Houston, Texas, United States
• Study site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.